Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III
Links shared publicly online about this topic.
- 895total visits
Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III
Suboxone (buprenorphine and naloxone) is used to treat opioid dependence. Includes Suboxone side effects, interactions and indications.
View full resource at drugs.com
Tags: Opiate Addiction Medication, Drug, Pharma, FDA, Suboxone
Most Recently Shared on September 6, 2010 at 1:02 am By:
Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublin... http://bit.ly/agjBs0 #drug
Advertisement
